Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30855094 | 0.99 | PIK3C3 (0.33) | PIK3C3 | |
| SCHEMBL29337897 | 0.79 | — | — | |
| SCHEMBL29334281 | 0.77 | TRPM5 (0.32) | — | |
| SCHEMBL30855007 | 0.75 | PIK3C3 (0.33) | PIK3C3 | |
| SCHEMBL29333597 | 0.75 | PIK3C3 (0.33) | PIK3C3 | |
| SCHEMBL30855168 | 0.73 | KCNK3 (0.37) | PIK3C3 | |
| SCHEMBL29334284 | 0.73 | KCNK3 (0.37) | PIK3C3 | |
| SCHEMBL30855163 | 0.73 | KCNK3 (0.37) | PIK3C3 | |
| SCHEMBL29333568 | 0.70 | KRAS (0.34) | PIK3C3 | |
| SCHEMBL29337867 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226114-A1 | INHIBITORS AND USES THEREOF | VIVIDION THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226114-A1 | INHIBITORS AND USES THEREOF | KEAP1, NQO1, NFE2L2 | PIK3C3 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.